Related Experiment Video
Updated: Oct 16, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Timing of antibiotic therapy in the ICU
Marin H Kollef1, Andrew F Shorr2, Matteo Bassetti3
1Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Avenue, MSC 8052-43-14, St. Louis, MO, 63110, USA. kollefm@wustl.edu.
Abstract:
Severe or life threatening infections are common among patients in the intensive care unit (ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial therapy for clinical resolution. Antibiotics are the cornerstone of therapy for infected critically ill patients. However, antibiotics are often not optimally administered resulting in less favorable patient outcomes including greater mortality. The timing of antibiotics in patients with life threatening infections including sepsis and septic shock is now recognized as one of the most important determinants of survival for this population. Individuals who have a delay in the administration of antibiotic therapy for serious infections can have a doubling or more in their mortality. Additionally, the timing of an appropriate antibiotic regimen, one that is active against the offending pathogens based on in vitro susceptibility, also influences survival. Thus not only is early empiric antibiotic administration important but the selection of those agents is crucial as well. The duration of antibiotic infusions, especially for β-lactams, can also influence antibiotic efficacy by increasing antimicrobial drug exposure for the offending pathogen. However, due to mounting antibiotic resistance, aggressive antimicrobial de-escalation based on microbiology results is necessary to counterbalance the pressures of early broad-spectrum antibiotic therapy. In this review, we examine time related variables impacting antibiotic optimization as it relates to the treatment of life threatening infections in the ICU. In addition to highlighting the importance of antibiotic timing in the ICU we hope to provide an approach to antimicrobials that also minimizes the unnecessary use of these agents. Such approaches will increasingly be linked to advances in molecular microbiology testing and artificial intelligence/machine learning. Such advances should help identify patients needing empiric antibiotic therapy at an earlier time point as well as the specific antibiotics required in order to avoid unnecessary administration of broad-spectrum antibiotics.
Insights
Timely and appropriate antibiotic administration is critical for critically ill patients in the intensive care unit (ICU). Optimizing antibiotic timing and selection improves survival and reduces mortality in severe infections like sepsis.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Background:
- Severe infections are frequent in intensive care units (ICUs), often requiring antimicrobial therapy.
- Suboptimal antibiotic administration in critically ill patients is linked to increased mortality.
- Antibiotic timing and appropriate drug selection are crucial for survival in sepsis and septic shock.
Purpose of the Study:
- To review time-related variables impacting antibiotic optimization for life-threatening ICU infections.
- To emphasize the importance of antibiotic timing and selection in improving patient outcomes.
- To propose strategies for minimizing unnecessary antibiotic use through de-escalation and advanced diagnostics.
Main Methods:
- Review of current literature on antibiotic administration timing and efficacy in ICUs.
- Analysis of factors influencing antibiotic exposure and patient survival.
- Discussion of emerging technologies like molecular microbiology and AI/machine learning for personalized therapy.
Main Results:
- Delayed antibiotic administration can significantly increase mortality in critically ill patients.
- Appropriate antibiotic selection based on in vitro susceptibility is vital for effective treatment.
- Optimizing infusion duration, particularly for beta-lactams, can enhance antimicrobial efficacy.
Conclusions:
- Early and appropriate antibiotic therapy is paramount for improving survival in ICU infections.
- Antimicrobial de-escalation guided by microbiology is essential to combat resistance.
- Future approaches integrating advanced diagnostics and AI/ML will enable earlier, more precise antibiotic interventions.
Related Concept Videos
Dosage Interval and Administration Route: Determination Methods
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection IV: Nursing Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

